The use of real-world evidence (RWE) in healthcare decision-making could significantly improve patient outcomes, improve care, reduce costs, and boost efficiencies in health care systems.
Increasing acceptance of the value of real-world evidence — along with the support of its use by the U.S. Food and Drug Administration (FDA) — is helping drive the adoption of new medication, devices and technology. However, multiple barriers continue to impede widespread implementation.
